Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Houstonian Terri Milton is determined not to let advanced fatty liver disease get the best of her.
It involves the buildup of fat in the liver.
Learn more about how NAFLD progresses and eventually leads to worsening liver damage.
Liver scarring was associated with poorer health outcomes and a higher risk of death for people with non-alcoholic fatty liver disease.
A triple regimen of Opdivo, Yervoy and Cabometyx showed good activity, but side effects may limit its use.
Transplants due to hepatitis C have declined dramatically thanks to effective treatment.
Those with fatty liver disease and cirrhosis should undergo regular screening.
I learned a lot about liver disease after his liver failed in 1980, never dreaming I would have cirrhosis later and need this knowledge.
Three fatty liver disease candidates miss the mark for effectiveness or safety.
The 2019 Liver Meeting in Boston provided an array of important findings about the treatment and prevention of chronic liver diseases.
Currently, there are no pharmacological treatments for liver fibrosis related to non-alcoholic steatohepatitis.
A pooled analysis of numerous clinical trials and real-world studies reached this conclusion.
Primary biliary cholangitis (PBC) is a chronic liver disease resulting from the destruction of the bile ducts in the liver.
People treated with Viread, Vemlidy or Baraclude are less likely to develop this malignancy.
A new classification system may more accurately reflect liver-related death trends in the United States.
This is the first major study to assess an eight-week regimen in people with all genotypes of hep C and compensated cirrhosis.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.